Patent · US Active

Anti-CD4 antibodies

US11254745B1 · kind B1 · utility

0Cited by
1References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 9, 2021
Grant dateFeb 22, 2022
Priority date—
Expiry dateMay 9, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides herein anti-CD4 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.